USP Delaying Revisions to <795> & <797>
The United States Pharmacopeia announced this week that the revisions to USP <795> (non-sterile compounding) and USP <797> (sterile compounding) published June 1, 2019, will be delayed. The updates to the two chapters were originally scheduled to take effect on December 1, 2019, but pending appeals require further review according to USP bylaws.
What appeals to <795> and <797> will the USP continue to review?
- Beyond Use Date (BUD) provisions
- Applicability to veterinary practitioners
- Alternative Technology provision in <797>
Read more about the USP's most recent decision on these appeals >
USP <800> will still take effect as of December 1, 2019. Compounding pharmacies that handle chemicals found on the NIOSH hazardous drugs list will need to continue with any renovations and changes to SOPs (standard operating procedures) that they began or have already completed in preparation for changes to guidelines for handling hazardous drugs.
While the USP says that they consider Chapter <800> informational only and not compendially applicable until the revisions to <797> are resolved, they include an important disclaimer that federal and state regulators will make their own decisions regarding enforcement.
Is your facility ready for USP <800>? Do you have any questions about complying with revised USP chapters?
Let us help: start by giving us a call at 877.LETCORX to talk to our Compounding Support Services team of experts.
Need more robust regulatory consulting?
Letco customers can get special pricing on services including readiness assessment, staff training, customizable SOP libraries, and more through our Regulatory Solutions Program.
Latest Articles
-
Posted: July 08, 2020Categories: Industry NewsRead more »
The Alliance for Pharmacy Compounding held their Advocacy Town Hall, which you can watch in its entirety...
-
Posted: June 25, 2020Categories: Industry NewsRead more »
A recent clinical trial from the UK showed decreased mortality for patients seriously ill with COVID-19 requiring oxygen or ventilators when treatment included the corticosteroid dexamethasone...
-
Posted: June 05, 2020Categories: Industry NewsRead more »
This week, two major medical journals retracted separate studies on Covid-19 treatments due to an inability to validate the data and methodology used in the studies.
-
Posted: May 29, 2020Categories: Compounding EducationRead more »
The Institute for Safe Medication Practices (ISMP) recently shared a medication error involving remdesivir vial labels that provides an important example for compounders...
-
Posted: May 14, 2020Categories: Compounding EducationRead more »
Change control SOPs are critical in sterile compounding - and pharmacy technicians are not the only ones who need to understand machines and tools in the lab and workflows.
-
Posted: May 11, 2020Categories: Compounding EducationRead more »
Formulations require different sample amounts to allow for an accurate result representative of the compounded preparation.
-
Posted: April 21, 2020Categories: Industry NewsRead more »
Covid-19 has led to a constantly changing regulatory environment to support patient care. But pharmacists need to take care to monitor national as well as state laws and guidelines.
-
Posted: April 17, 2020Categories: Compounding EducationRead more »
Download our one-page flyer with tips and resources to help support the service your pharmacy and staff are providing to your communities.
